Modeling of E-cigarette Use. David Levy, PhD Georgetown University

Similar documents
Competition in the Vaporized Nicotine Market and its Potential Impact on the Cigarette Market. David T. Levy Georgetown University

The Evidence on E-cigarettes: Evaluating What We Have and Identifying What We Need

How to Regulate E-Cigarettes? Are we asking the right questions?

REGULATORY OPTIONS FOR MOVING TO THE ELIMINATION OF SMOKING. Ron Borland PhD

Modeling the Population Health Effects of Camel Snus with Reduced Risk Information

Predicting the population health effects of changing tobacco exposures: Statistical models for regulatory compliance

ELECTRONIC CIGARETTES WHAT S THE BOTTOM LINE?

FDLI Tobacco Products Regulation and Policy Conference Joe Murillo Vice President, Regulatory Affairs October 27, 2017

Why comprehensive TC is essential for successful harm reduction

National Conference of State Legislatures Legislative Summit: Clearing the Air About E-Cigarettes

Should FDA try to move smokers to e-cigarettes or other less harmful tobacco-nicotine products and, if so, how?

Recent Findings from the ITC Project on the Effectiveness of Health Warnings in the Asia Pacific Region

Menthol cigarettes are a public health problem

E-Cigarette Vaping: The Good, the Bad and the Ugly

Problem Which option Additional option Additional comments definition Yes No change No further observations.

Melodie Tilson, Director of Policy

The Latest on Vaping Among U.S. Teens

Fumo, riduzione del danno e rischio oncologico

Use of e-cigarettes (vapourisers) among adults in Great Britain

UNITED STATES REGULATION OF TOBACCO PRODUCTS. Presented by Mitch Zeller Center Director FDA Center for Tobacco Products

David T. Levy, Ph.D. Lombardi Comprehensive Cancer Center

American Vaping Association

Texas Bill to Regulate Vapor Products. Over the past few years, electronic cigarettes, also commonly referred to as e-cigarettes

Survey to Measure the Effectiveness of Electronic Cigarettes - October 2012

Policy Options for the Regulation of Electronic Cigarettes

Electronic Nicotine Delivery Systems: Patterns of Use and Disparities

Evaluating Interventions to Curb ENDS Use Among Utah Youth

Communicating the Risk of Nicotine Delivery Products

Smoking Harm Reduction: If Not Now When?

The cost-effectiveness of raising the legal smoking age in California Ahmad S

Prevent disease Protect from injury Promote healthy lifestyles

E-Cigarettes: A Game Changer. Dr. Blake Brown Hugh C. Kiger Professor Agriculture and Resource Economics College of Agriculture & Life Sciences

Tobacco-related risk perceptions in the regulation of tobacco products at the FDA Center for Tobacco Products

Tobacco Control Policy and Legislation Antero Heloma, MD, PhD Principal Medical Adviser. 20/03/2012 Presentation name / Author 1

RADM Patrick O Carroll, MD, MPH Senior Advisor, Assistant Secretary for Health, US DHSS

Electronic Cigarettes: What They Are, How They re Marketed, & How We Can Protect Our Youth

Health behavior science and global public health:

Improving E-Cigarette Research through Measurement and Design ANDREA VILLANTI, PHD MPH E-CIGARETTE SUMMIT MAY 8, 2017

PROJECT NEWS. Youth and Young Adult Vaping in Canada. Background. Methods. Key Findings

Public Health England s Independent Expert E-Cigarettes Evidence Review

Wayne Hall and Coral Gartner University of Queensland

Non-Industry Voices on Tobacco Harm Reduction and Vaping Products

Policy Options for the Regulation of Electronic Cigarettes

Electronic cigarettes: A new era for tobacco harm reduction Adapted for SW Specialist Nurses for Children in Care meeting 17 January 2017

E.cigarettes. An alternative to a uniquely deadly product that kills one in two of its regular users? Paul Lambert Public Health, Leeds City Council

The alcohol market is in need of a thorough review

How to think AND feel about nicotine and the people who use it

Tobacco Surveillance and Evaluation: An Update

Country profile. Gambia. Note: Where no data were available, " " shows in the table. Where data were not required, " " shows in the table.

Use of electronic cigarettes (vapourisers) among adults in Great Britain

Tobacco Product Regulation: FDA s Economic Impact Analysis Frank J. Chaloupka University of Illinois at Chicago

The Effects of E-Cigarette Warning Labels among Yong Adult Non-Smokers. Darren Mays, PhD, MPH Georgetown University

Consultation on Electronic Cigarettes. Analysis of submissions

EXECUTIVE SUMMARY. 1 P age

Discussion points on Bill S-5

FDA s Action Agenda to Reduce Tobacco Related-Cancer Incidence and Mortality

Global E-Cigarette Market- Industry Analysis & Outlook ( )

Policy Options for the Regulation of Electronic Cigarettes

The Voice of Local Public Health in New York State. May 12, 2014

Russia SimSmoke: the long-term effects of tobacco control policies on smoking prevalence and smoking-attributable deaths in Russia

Plain Packaging of Tobacco Products FAQ

Next Wave of Open System Device Consumers

ESPs are battery-operated devices that contain cartridges filled with liquid chemicals. The chemicals turn into a vapour that the user inhales (this

MARKETING STANDARDS FOR MEMBERSHIP

Research Study: Court-Ordered Corrections of Tobacco Industry Racketeering PRELIMINARY REPORT Background Methods Results Conclusions

Effectiveness of electronic cigarettes for smoking substitution

12 Vaping Stats & Trends for the Informed E-Cig Retailer

MDQuit Best Practices Conference January 26, Presented by William C. Tilburg Deputy Director

The Independent British Vape Trade Association (IBVTA) welcomes the opportunity to respond to this consultation.

TOBACCO PLAYBOOK DÉJÀ VU: E-CIGARETTES MICHIGAN CANCER CONSORTIUM MARCH 26, 2014

Country profile. Myanmar

Submission to the Oireachtas Joint Committee on Health and Children

YOUR GUIDE TO TOBACCO LEGISLATION

Country profile. Nepal

Excise duties applied to manufactured tobacco

Codebook Section 1. Tweet Information. Section 2: Inclusion/Exclusion

E-cigarettes and personal vapourisers: current research and policy

Helping Smokers to Quit in General Practice

THE ECONOMICS OF TOBACCO AND TOBACCO TAXATION IN BANGLADESH

CREATING A TOBACCO-FREE GENERATION A Tobacco Control Strategy for Scotland. Dr Catherine Calderwood Chief Medical Officer For Scotland

Menthol Cigarettes, Smoking Cessation, Atherosclerosis and Pulmonary Function

Population impacts of snus tobacco initiation and cessation

The Tobacco and Vaping Products Act: Implications for E-Cigarette Point-of-Sale Promotion

Electronic Nicotine Delivery Systems

Geoffrey T. Fong, Ph.D. Department of Psychology University of Waterloo and Ontario Institute for Cancer Research

Country profile. Timor-Leste

Tobacco use among african-americans in Minnesota :

Tobacco 21 in Oregon 7,000. Leading Causes of Preventable Death in Oregon. Most addiction to tobacco starts in adolescence.

5,000. Number of cigarettes 4,000 3,000 2,000 1,000

Key Elements of this Presentation. Smoking Still Main Cause of Premature Death 31/10/2013. The Case for Plain Packaging

The plain truth: Australia s world first plain packaging legislation

Coach on Call. Thank you for your interest in E-Cigarettes: Your Questions Answered. I hope you find this tip sheet helpful.

Is Vaping a Valid Strategy for Smoking Cessation? Myths and Facts Jaspreet S. Brar. MD, PhD Community Care Behavioral Health Organization

Flavors Hook Kids. The Tobacco Industry s Kids Menu MARIPOSA COUNTY HEALTH DEPARTMENT

Tobacco-Control Policy Workshop:

ACS Submission: Consultation on the advertising of electronic cigarettes


Dual Use: If Electronic Cigarettes are so good, why are there so few exclusive users?. Jonathan Foulds, PhD

Country profile. Lebanon

Transcription:

Modeling of E-cigarette Use David Levy, PhD Georgetown University

No Conflicts of Interest Funding has been received for this work from NIDA (NIH) under grant R01DA036497, NCI CISNET U01CA199284, and the National Cancer Institute under grant P01CA200512 (ITC). Contributors: David Abrams, Ron Borland, K. Michael Cummings, Geoffrey T. Fong, Ted Holford, Rafael Meza, Ray Niaura, Andrea Villanti

Purposes of Modeling Examining Past Behavior: Past Policies-> Smoking Behaviors -> Health Outcomes Potential Future Public Health Impacts: Potential Future Policies (given current policies) -> E-Cigarette and Cigarette Use Patterns -> Health Outcomes Heuristic: Understanding system aspects, helping to determine the information needed to evaluate public health impacts***

Models needed, but It's tough to make predictions, especially about the future. Yogi Berra In theory, there is no difference between theory and practice. In practice, there is. Yogi Berra If you don't know where you are going, you will wind up somewhere else! Yogi Berra

Modified Risk Product: Previous Models: All cohort-based* Scandia model (Vugrin et al)* Industry model (Bachand and Sulsky; Bachand, Sulsky, Curtin, Risk Anal; Poland B, Teischinger, NTR; Weitkunat et al., Reg Tox)* E-: Kalkhoran and Glantz (2016)* E-: Cobb et al. (2015) * E-: Cherng et al (2016) E-: Levy et al (2016, 2017) Warner & Mendez* * While these models follow cohorts, they focus on age => problematic results. The projections are dependent on constant initiation rates and cessation rates by 5 age based on data for a specific time period

Reasons to Focus on Cohort Use rates highly dependent on age and surrounding circumstances for a given cohort Awareness and perceived risk Available products with differing appeal, ability to satisfy cravings Differing policies, especially price of e-cigs relative to Circumstances at early ages affect later ages (potential to try and progress, past experiences) Evidence that e-cigarette use rates changing considerably by age group over time is suggestive of important cohort effects 6

Levy et al. model (2016, NTR) Unlike earlier models, focuses on a representative single cohort: age 15 in 2012 Applies a decision-theoretic framework (Levy et al. 2017, Addiction) grounded in a public health approach to examine the effect of transitions to final states of established use. Public health implications depend on the counterfactual of what would have happened in the absence of e-cigarette use Distinguishes trial use from established e-cigarette use With trial use, individuals may transition to: 1) exclusive e- cigarette use, 2) dual (cig and e-cig) use, 3) exclusive cigarette use, or 4) no use (e- as transition to quitting both). 7

THE PUBLIC HEALTH IMPACT OF E-CIGARETTE USE AMONG NEVER SMOKERS Green indicates public health benefit Red indicates public health harm Never Smoker Would have become a smoker in the absence of e- Would NOT have become a smoker absent e- TRANSITIONAL E-CIGARETTE USE Does not try e- Try e- Try e- Does not try e- Quit e- cigarette use Continue to use e- Quit e- Continue to use e- LONG-TERM USE Long-term cigarette smoker Long-term cigarette smoker Does not smoke or use e- Long-term dual user (reduced quantity) Long-term e- cigarette use Long-term cigarette smoker Does not smoke or use e- Long-term dual user Long-term e- cigarette use only Does not smoke or use e-

Status Quo (smoking only) Counterfactual Prevalence by current, former and never smoker using NHIS data through 2010 (Holford et al. AJPM, 2013) updated to 2012 (Holford et al, JAMA 2014). CISNET data developed using age-period-cohort model correcting for differential mortality Projections based on NHIS data through 2012 based on initiation and cessation rates (measured as 2 year quit = cessation net of relapse) before significant e-cigarette use Death rates based on CPS-I and CPS-II data (recent data suggests higher risks) vary by age and gender and by current, former (reflecting years quit) and never smokers

Results: US Males for 1997 cohort Scenario Measure Age 15 25 45 65 85 Status quo Prevalence Smoker 4.6% 20.4% 12.7% 5.6% 1.1% Cumulative Ages 15-85 Difference from Status Quo SADs - - 581 2,116 2,816 79,322 LYL - - 23,573 46,335 16,706 1,539,242 Best Prevalence Smoker 2.8% 12.4% 7.7% 3.4% 0.6% E- cigarette 1.3% 5.9% 3.7% 1.6% 0.3% Dual 1.3% 5.9% 3.7% 1.6% 0.3% Low Risk SADs - - 442 1,522 1,879 56,213 23,109 LYL - - 17,921 33,313 11,147 1,112,151 427,091 Low-mid Estimate SADs - - 480 1,653 2,041 61,058 18,264 LYL - - 19,465 36,184 12,108 1,208,000 331,242 Medium Risk SADs - - 514 1,769 2,185 65,365 13,958 LYL - - 20,838 38,736 12,962 1,293,200 246,042 High risk SADs - - 565 1,944 2,401 71,824 7,498 LYL - - 22,898 42,564 14,243 1,421,000 118,242

Life years gained Life year gained Male Regular Use Sensitivity Analysis Male Dual Use Sensitivity Analysis 600,000 600,000 500,000 400,000 400,000 200,000 300,000 - (200,000) 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% 200,000 100,000-0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% (400,000) (100,000) (600,000) Percentage Otherwise Smoker Otherwise Non-Smoker Low risk Low mid-risk Medium risk High risk (200,000) Percentage Otherwise Smoker Otherwise Non-Smoker Low risk Low-mid risk Medium risk High risk

Implications Public health benefits are projected over a wide range of parameters Results insensitive to future cessation (not shown) Results sensitive to use rates of otherwise smokers vs otherwise non-smokers especially at low risk-> need to continue making less appealing (cig taxes, etc), but adopt policies that discourage use by otherwise never smokers (raised MLPA, taxes?) Results depend on toxicity-> may reduce harms to users and encourage exclusive rather than dual use Results are highly sensitive to initial use and transition measures

THE PUBLIC HEALTH IMPACT OF E-CIGARETTE USE AMONG CURRENT SMOKERS TRANSITIONAL E-CIGARETTE USE LONG-TERM use Does not try e- Former smoker Current Smoker Would have quit in the absence of e- Would not have quit in the absence of e- Tries e- * Tries e- Quit e- Continues to use e- Quits e- Continues to use e-* Continue smoking Former smoker Dual user* Former smoker, e-cigarette user Continue smoking Former smoker* Dual user Former smoker, e-cigarette user Does not try e- Long-term Smoker

What could be? Previous work projected potential effects, but limited by data, particularly the ability to distinguish cohort effects Most recent paper (Tobacco control) looks at the potential impact of e- on public health => way to get to the cigarette endgame Two scenarios: optimistic and pessimistic

THE TWO SCENARIOS ASSUMPTIONS OPTIMISTIC 1. Excess mortality risk of e- at 5% that of 2. Cessation from and e- at the 100% the rate of cigarette cessation pre-strategy 3. Initiation at the 100% the rate of cigarette initiation pre-strategy 4. Residual cigarette prevalence of 5% after 10 years PESSIMISTIC 1. Excess mortality risk of e- at 40% that of 2. Cessation from and e- at the 50% the rate cigarette cessation pre-strategy 3. Initiation at the 150% the rate of cigarette initiation pre-strategy 4. Residual cigarette prevalence of 10% after 10 years

THE TWO SCENARIOS STRUCTURE Both scenarios involve switching from to e- over a ten year period to the residual cigarette prevalence Project from 2016 to 2100 by age and gender for US Model includes current and former cigarette and e- cigarette prevalence Model calculates cigarette and e-cigarette attributable deaths and life year lost

Status Quo and E-Cigarette Substitution, Premature Deaths and Life Years Lost For All US Cohorts, Males and Females Combined OUTCOME Year 2016 2026 2060 2080 2100 Cumulative (2016-2100) Deaths Prevented/ Life Years Gained** % Change relative to status quo Status Quo Scenario* Premature Deaths 461,588 470,743 316,556 167,037 2,905 26,065,448 Life Years Lost 5,689,458 5,625,286 2,626,503 685,593 1,852 248,639,532 Optimistic Scenario Premature Deaths 461,588 380,832 233,243 56,399 459 19,484,289 6,581,159-25.2% Life Years Lost 5,689,458 3,839,765 1,345,385 183,297 294 161,905,579 86,733,953-34.9% Pessimistic Scenario Premature Deaths 461,588 456,297 298,689 127,706 2,188 24,432,065 1,633,383-6.3% Life Years Lost 5,689,458 5,261,398 2,319,388 528,926 1,396 227,835,203 20,804,329-8.4% * Status Quo Scenario: Smoking Rates evolve from initial 2016 levels based on age, gender and cohort-specific smoking initiation and cessation rates in the absence of e-cigarette use ** Life Years gained = Life years lost in Status Quo - Life years lost in E-cigarette Substitution Scenario

Results and Implications Even under pessimistic (worst case scenario), there are gains from a strategy of encouraging switching from to e- Next step to model policies to encourage reduced smoking: two pronged approach Stronger policies against (now better justified): Traditional Policies- increase cigarette taxes, extend smoke-free air laws, greater retail compliance with minimum purchase New policies- implement strong graphic warnings, raise minimum purchase age, ban retail displays (ban slotting allowances?). Nicotine reduction? Policies encouraging switching to e-

Policies to Encourage E- Policies Content unrestricted: toxicity, flavors Marketing restrictions, incl. retail point of sale Taxes: e-cigarette & cigarette Smoke-free air laws Messaging regarding risks: media, packaging, news and websites Impacts Direct on product toxicity, flavorings, types, costs, where used and consumer knowledge Indirect through market structure: Independents have different incentives than cigarette firm (protecting profitability of )

Structure of VNP Industry Stage One: Components Disposables Reusables: DEVICES Closed systems Open systems Stage Two: Device Marketing CIGARETTE MANUFACTURERS Mostly disposables and refillable devices Stage Three: Consumer Channels Conventional Retail Markets Other retail: tobacconists, kiosks LIQUIDS INDEPENDENTS All kinds of devices, including tanks and mods Vape Shops Internet

Conclusions E-cigarette use has beneficial public health impact over a wide range of plausible values Cohort analysis is central, will need to examine age patterns over time by cohort Will need better measures of use, especially established use (exclusive and dual) Much will depend on products available (esp HNB) Government regulation and industry structure are likely to play an important role Now working on model for England, hope to have results soon

You can observe a lot by just watching. Yogi Berra Yogi Berra's wife recently asked, "Yogi, when you die, where do you want to be buried, in Montclair, New York or in St. Louis?" Yogi: "I don't know, Carmen, why don't you surprise me?